🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is being performed to comply with regulatory requirements that a...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-11-17
Trial ID
NCT02293148
This is a randomized, double blind, placebo and active (moxifloxacin open l...
Status
Completed
Location
Celerion, Inc.
Start Date
2023-07-11
Trial ID
NCT05927649
Treatments Being Tested
The purpose of this study is to determine whether BMS-791325 has an effect ...
Status
Completed
Location
Ppd Development, Llc
Start Date
2014-04
Trial ID
NCT02084953
Treatments Being Tested
The purpose of this study is to examine the effect of buprenorphine on QT i...
Status
Completed
Location
PPD Development, LP, Clinics
Start Date
2004-07
Trial ID
NCT01148537
The purpose of this study is to determine if Moxidex otic solution is safe ...
Status
Terminated
Location
Contact Alcon Call Center for Trial Locations
Start Date
2010-02
Trial ID
NCT01071902
Treatments Being Tested
The purpose of this study is to evaluate the effect of CC-99677 coadministr...
Status
Completed
Location
Qps-Mra, Llc
Start Date
2020-09-30
Trial ID
NCT04718636
Treatments Being Tested
This is a randomized, placebo-controlled, double-blind, 3-way crossover pha...
Status
Completed
Location
Research Site
Start Date
2017-09-06
Trial ID
NCT03258515
Treatments Being Tested
This study is designed to evaluate repeat doses of isavuconazole on cardiac...
Status
Completed
Location
Parexel
Start Date
2012-03
Trial ID
NCT01565720
Treatments Being Tested
The Phase I Thorough QT/QTc (TQT) study will be performed in a single cente...
Status
Completed
Location
Vince and Associates Clinical Research
Start Date
2018-09-25
Trial ID
NCT03613649
Treatments Being Tested
Evaluate the effect of multiple doses (once daily for 3 days each of HYD 80...
Status
Completed
Location
PPD Phase I Clinic
Start Date
2012-11
Trial ID
NCT02243241
Treatments Being Tested